Abstract
Clinically significant endemic mycoses (fungal infections) in the United States (U.S.) include Blastomyces dermatitidis, Histoplasma capsulatum, and Coccidioides immitis/posadasii. While the majority of infections go clinically unnoticed, symptomatic disease can occur in immunocompromised or hospitalized patients, and occasionally in immune-competent individuals. Clinical manifestations vary widely and their diagnosis may require fungal culture, making the rapid diagnosis a challenge. Imaging can be helpful in making a clinical diagnosis prior to laboratory confirmation, as well as assist in characterizing disease extent and severity. In this review, we discuss the three major endemic fungal infections that occur in the U.S., including mycology, epidemiology, clinical presentations, and typical imaging features with an emphasis on the pediatric population.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Endemic mycoses are caused by a diverse group of fungi that occur in particular geographic locations. In the United States (U.S.), common endemic mycoses include Blastomyces dermatitidis, Histoplasma capsulatum, and Coccidioides immitis/posadasii [1]. Most infections caused by these organisms are asymptomatic. Symptomatic endemic mycoses most commonly present as opportunistic infections in immunocompromised or hospitalized patients, although symptomatic infections occasionally occur in immune-competent individuals. Clinical presentations vary from non-specific symptoms such as fatigue, fever, and weight-loss to more specific symptoms involving the central nervous system (CNS), musculoskeletal system, and skin [2].
Imaging findings, combined with patient history, geographic location, and clinical course can help in reaching an exact diagnosis. Most literature regarding imaging of endemic fungal infections pertains to the adult population, with few publications including pediatric patients [2,3,4,5]. As such, our understanding of imaging of pediatric endemic mycoses is largely extrapolated. Yet, emerging research in related fields, such as invasive fungal infections, demonstrates that radiologic manifestations of diseases in children can differ significantly from those in adults, suggesting the need for understanding of the imaging manifestations of endemic fungal infection specific to the pediatric population [6]. In this review, we aim to discuss both the thoracic and extra-thoracic imaging findings that we have observed in children with endemic mycoses. Mycology, epidemiology, common clinical presentations, and diagnostic techniques will also be discussed.
Overview of endemic mycoses
All three fungi being discussed are saprophytic, meaning that they feed on decaying organic matter. Exact case numbers are difficult to determine due to differing reporting criteria among states and asymptomatic disease going unrecognized [7,8,9], but estimated annual incidences of blastomycosis, histoplasmosis, and coccidioidomycosis range between 0 and 121 reported cases per 100,000 population [10,11,12]. The frequency of hospitalization (4.6 and 28.7 cases per 1 million children and adults, respectively) and mortality (5% and 7% of infected children and adults, respectively) are likely inaccurate [1, 13]. In the pediatric population, emerging research discusses the use of C-reactive protein and procalcitonin to differentiate fungal from bacterial infection, with procalcitonin levels being increased in bacterial infections but not in fungal disease [14, 15].
Blastomycosis
Epidemiology
Blastomyces dermatitidis is endemic to the Mississippi and Ohio River basin, Great Lakes region, and Southeastern U.S. [16]. Individuals who participate in outdoor activities (e.g., hiking, hunting, fishing) are more likely to be exposed. Incidence in hyperendemic regions, such as Vilas County, Wisconsin, is reported to be 40 cases/100,000 people [15]. Approximately 3–10% of reported cases occur in children [17].
Mycology
B. dermatitidis is a dimorphic haploid ascomycota. In its typical moist soil environment at 22–30 °C, its mycelia exist as septate hyphae with a single conidium (spore) attached to a conidiophore. When disturbed, the fungus’ spores fragment from the rest of the hyphae and are released into the air. Mammals in close proximity inhale the aerosolized spores. Once inside the host’s lungs, the spores undergo phase transition and convert to a pathogenic multinucleate broad-based budding yeast (Fig. 1) [18, 19].
Pathogenesis
A number of virulence factors are acquired after B. dermatitidis undergoes phase transition. Yeast cells are larger with thicker cell walls, making phagocytosis by the host immune cells more difficult. Adhesion proteins called Blastomyces adhesin-1 (BAD-1) are expressed on the cell surface that possesses a high affinity for human lung tissue and extracellular matrix, allowing for further evasion of the host’s immune system, yeast replication, and, potentially, lymphohematogenous dissemination [20,21,22].
Clinical presentation
B. dermatitidis is comparatively less dependent on host immunocompromise than other dimorphic fungi and more frequently causes symptomatic disease in immunocompetent patients. Commonly, blastomycosis presents as a chronic isolated pulmonary disease, with cough being the most sensitive symptom. It is frequently accompanied with dyspnea, sputum production, and systemic signs, such as fever, chills, and fatigue, overlapping with community-acquired pneumonia or tuberculosis [23]. In rare cases, acute respiratory distress syndrome (ARDS) may develop, which is often the cause of death in children with blastomycosis [15, 17, 24].
Extrapulmonary disease is less common and rarely occurs in isolation. The skin is primarily involved, with skin lesions ranging from verrucous to ulcerative in appearance. Dissemination to the bone, causing osteomyelitis, may also occur [25]. CNS blastomycosis is rare, most commonly affecting immunocompromised patients with acquired immune deficiency syndrome (AIDS). It can manifest with headaches and has a lower mortality rate in children than in the adult population [26].
Diagnosis
The most common method for diagnosing blastomycosis is multimedia culturing of biopsy or sputum specimens. Cultures can be confirmatory even when histology is negative [27]. Given that yeast growth is rarely apparent before 5 days of culturing and may take as long as 30 days, for prompt identification (less than 1 to 2 days), histologic or cytologic assessment of bronchoalveolar lavage (BAL) can facilitate timely treatment (Fig. 2) [27, 28]. Irrespective of the anatomic site or tissue involvement, classic lesions present as necrotizing granulomas, containing round yeasts with single buds. Their broad-based budding morphology with thick refractile walls is essentially pathognomonic among human pathogens and is highlighted on Grocott methenamine silver (GMS) or periodic acid-Schiff (PAS) stains (Fig. 2) [28, 29]. Occasionally, the yeast morphology overlaps with other fungi requiring confirmation by culture [27, 28]. Alternative methods include serum and urine antigen testing, which has proven reliable for rapid diagnosis, but has limited specificity and should not be used for diagnosis confirmation [30, 31].
Treatment
Primary treatment goals emphasize early intervention to prevent dissemination (primarily hematogenous) and ARDS. Although some cases are self-limiting, persistent mild pulmonary infections may require an oral azole antifungal medication [32]. More severe or disseminated cases will require amphotericin-based compounds that offer better tissue penetrance [33]. Some initial data suggest that serology antigen and antibody levels may be used to track therapeutic response [15, 34,35,36,37].
Coccidioidomycosis
Epidemiology
Coccidioides immitis and Coccidioides posadasii are endemic to the Southwestern U.S., northern Mexico, and Brazil [16]. The two are clinically indistinguishable but differ in geographic distribution. In its pathogenic form, coccidioidomycosis, also known as “San Joaquin Sun Valley Fever,” has been reported in 22 states. Farmers, military personnel, and excavators are at the greatest risk. Periods of drought that follow heavy rain increase the risk of exposure, because the species reside in dry alkaline soil, where they feed and grow off animals’ food and their carcasses [38]. The incidence of coccidiomycosis ranges from 0 to 42.6/100,000 population [12]. Pediatric cases account for 9.2% of the reported annual incidence and have a slightly higher mortality rate compared with adult cases (3.2% in children vs 2.7% in adults) [39, 40].
Mycology
Coccidiodes spp. mycelium exists as septate hyphae that link single-cell barrel-shaped arthroconidia (spores). In mammalian host’s lungs, the arthroconidia phase transitions into pathogenic spherules that, internally, grow and host many endospores. Aside from these structural differences, the mycology of Coccidiodes spp. is comparable to that of B. dermatitidis [38, 39].
Pathogenesis
Once phase transition has taken place inside the host’s terminal bronchioles, coccidioidomycosis primarily relies on its rapid growth ability for virulence to outpace the host’s immune system. Spherules undergo synchronous division of nuclei and eventually rupture, releasing hundreds of endospores. Each endospore has the potential to become a new spherule and the process is repeated. Spherules are too large for phagocytosis so the host immune system relies on antibody-mediated and T-cell immunity [41]. Generally, host cellular immunity can adequately control coccidioidal infection, making virulence greatly dependent on the immune status of the host [40].
Clinical presentation
Nearly 60% of coccidioidomycosis infections are asymptomatic or self-limited [40]. In the remaining patients, severity usually depends on the patient’s immune system status. Coccidioidomycosis can be classified as primary or secondary. The primary disease usually manifests in the lungs with associated flu-like syndrome termed “San Joaquin Sun Valley Fever.” Acutely, patients typically develop fever, cough, chest pain, headache, fatigue, and arthralgias, and, on rare occasions, develop pneumonia and respiratory failure. Chronically, especially if left untreated, local lung infections can evolve into diffuse pulmonary disease, pericarditis, mediastinitis, pleural effusions, empyema, and lung abscess [37, 42]. Coccidioidomycosis is commonly mistaken for bacterial pneumonia. In hyperendemic regions, coccidioidomycosis is responsible for up to 25% of community-acquired pneumonia cases [40].
The secondary disease occurs when infection extends or disseminates beyond the primary site to other organs. In addition to primary disease symptoms, the disseminated disease is accompanied by night sweats, weight loss, and lymphadenopathy. In symptomatic pediatric coccidioidomycosis, disseminated disease occurs in up to 81% of cases and is most likely to occur in bones and joints [43, 44]. CNS infection, while uncommon, is the most serious form of secondary disease, with coccidioidal meningitis usually presenting with headache, nausea and vomiting, altered mental status, and fever. While the skin is the most common site of dissemination in adults with secondary disease (occurring in almost 70% of cases), it occurs much less frequently in children (less than 10% of cases). Skin involvement can manifest as erythema nodosum [40, 43].
Diagnosis
The mainstay method for diagnosis of coccidioidomycosis is the serologic detection of IgG and IgM antibodies [45]. False-negative results are a significant pitfall both in the (severely) immunocompromised and in the setting of new-onset disease, as antibodies may take weeks to develop [35]. False negative serology was reported in approximately 38% of patients with hematogenous infection and 46% of fatal cases in a retrospective study [46]. Histologically, classic lesions present with necrotizing granulomatous inflammation (Fig. 3). Large thick-walled spherules contain numerous endospores and may be seen with routine H&E stains (Fig. 4) [47]. Ruptured spherules spill their endospores into surrounding tissues, which can be highlighted on special stains (GMS and PAS) [48]. A definitive diagnosis of Coccidioides requires the unequivocal presence of endospore-containing spherules [49]. Detection by polymerase chain reaction methods is emerging as an alternative rapid diagnostic approach [50].
Treatment
Coccidiomycosis treatment typically is focused on patient reassurance and education as most cases are self-limited. Oral azole antifungals are typically reserved for severe disease, including CNS involvement, and in immunocompromised patients. In more severe pulmonary disease or systemic dissemination, pharmacological management may be long-term, sometimes beyond a year, due to the fact that Coccidioidomycosis maintains a high potential for latency. Surgical intervention is more commonly required in children but typically reserved for extreme cavitary pulmonary disease and disease affecting bones and joints [40, 42, 51, 52].
Histoplasmosis
Epidemiology
Histoplasma capsulatum is endemic to the Mississippi and Ohio River basins of the U.S., Central America, Southeast Asia, and the Mediterranean [16]. Its pathogenic form, histoplasmosis, has been reported in 12 states. People who spend time occupying empty buildings, farms, and caves are at the greatest risk of exposure, as H. capsulatum is often found in soils contaminated with bird and bat guano. Occupational risk factors include cleaning, excavating, or exploring said locations [53, 54]. Although annual incidence rates ranged from 0 to 39 cases/100,000 population, histoplasmosis is considered to be the most prevalent endemic mycosis in North America [55]. Incidence in children is difficult to determine as children are more likely to be asymptomatic even with greater exposures [53, 56].
Mycology
H. capsulatum’s mycelium exists as septate hyphae that have spiky macroconidia and smooth microconidia (spores). Inside the mammalian host’s lungs, the spores undergo a phase transition and convert to a pathogenic oval budding yeast. Aside from these structural differences, the mycology of H. capsulatum is also comparable to B. dermatitidis [19, 57, 58].
Pathogenesis
Due to their small size, H. capsulatum spores can bypass the host’s mucosal immune system barriers reaching the alveoli, where they phase transition into yeast. Immediately after phase transition, there is an increase in heat shock proteins expression on Histoplasma’s cell surface. These proteins promote phagocytosis by acting as a ligand for macrophage cell surface receptors [59]. Other changes in protein production influenced by the phase transition allow histoplasmosis to reduce host pro-inflammatory responses, inactivate reactive oxygen and nitrogen species, and promote nutrition production and transport from within the macrophage [60, 61]. Histoplasmosis outgrows the phagocyte and induces intracellular apoptosis of the cell to result in the release of the yeast. The yeast is then engulfed by other macrophages, allowing for transportation to nearby (and occasionally distant) lymph nodes and then the rest of the reticuloendothelial system (e.g., spleen) for dissemination. An immunocompetent host usually mounts an effective defense once they develop T-cell immunity via dendritic cells, making histoplasmosis virulence generally dependent upon host immune status [62, 63].
Clinical presentation
Nearly 99% of histoplasmosis cases are asymptomatic [57]. Symptomatic cases are at greater risk of more severe primary and overwhelming disseminated infection. When symptoms do develop, histoplasmosis can be divided into acute, subacute, and chronic infections. Acutely, it presents in severely immunocompromised patients and very young children, usually causing pulmonary disease [63]. If symptomatic, patients most often exhibit cough followed by fatigue, shortness of breath, and fever. Illness severity ranges from self-limiting, mild disease to life-threatening pneumonia and ARDS. If symptoms last for greater than 1 month, the disease is termed subacute pulmonary histoplasmosis. In these cases, patients often develop systemic signs of inflammation such as pericarditis, erythema nodosum, pleuritis, and polyarthritis. After 3 months, the disease is termed chronic pulmonary histoplasmosis [64]. In these instances, cavitary lung disease can occur with associated symptoms of weight loss, productive cough, and hemoptysis. In both acute and chronic infections, both lymphatic and hematogenous dissemination may occur with hilar, mediastinal, and peripheral lymphadenopathy, miliary pneumonia, hepatosplenomegaly, bone marrow suppression, skin and mucosal lesions, and altered mental status. Miliary histoplasmosis, also referred to as disseminated histoplasmosis, presents with the classic military pattern on imaging that can mimic tuberculosis. Hepatosplenomegaly occurs in almost 90% of infants with disseminated disease [53, 57, 65,66,67].
Diagnosis
For rapid diagnosis, Histoplasma antigen detection immunoassays are typically performed on urine or serum samples as well as on BAL and/or cerebral spinal fluid (CSF) [68]. Assays detecting antibodies may show false-negative results (as seen in coccidiomycosis). For confirmatory diagnosis, the organism can be cultured from fluids and in tissue and directly visualized under microscopy [58,59,60]. Morphologically, Histoplasma capsulatum is a round to oval yeast with occasional tapered ends and narrow-based buds that are highlighted by GMS stain (Fig. 5) [48]. In acute disease, variable numbers of yeasts are seen in necrotic areas of distal airspaces, with an interstitial lymphohistiocytic inflammatory response. Chronic pulmonary histoplasmosis demonstrates more classic necrotizing granulomas, ultimately with calcifications and stromal hyalinization (Figs. 6 and 7) [69]. Such inactive burnt-out lesions may be identified radiologically.
Treatment
Treatment approaches are similar to blastomycosis, including oral azoles and amphotericin-based compounds for symptomatic infections [32, 35, 37, 70].
Imaging findings
Given the limitations of diagnostic testing, the diagnosis and management of endemic fungal infections can be challenging. Imaging can play an important role in prompt diagnosis and intervention. The following section reviews the intra- and extra-thoracic imaging manifestations of endemic mycoses in the pediatric population, with emphasis on findings that are particularly suggestive of endemic fungal infection in general or even specific fungal organisms.
Thoracic imaging manifestations
Consolidation
Lung consolidation can be seen with any endemic fungal infection (Figs. 8, 9, 10, 11, 12, and 13), typically in the setting of acute or initial infection, and is particularly common with blastomycosis (Figs. 8 and 9) [37, 71]. Fungal consolidation appears as variable-sized confluent or patchy lung opacities that obscure the margins of vessels and bronchial walls, often with ill-defined margins and air bronchograms and sometimes with cavitation (Fig. 10) [72].
Consolidation is most often unilateral and segmental or lobar, without any regional predilection [73], frequently mimicking community-acquired pneumonia (Figs. 8, 11, and 12). However, in the setting of severe exposure, histoplasmosis can present with widespread consolidation [74]. Consolidation, particularly that associated with blastomycosis, can also appear mass-like (Fig. 9), mimicking neoplastic processes, pulmonary infarcts, or inflammatory processes, such as granulomatosis with polyangiitis or organizing pneumonia [75] (Tables 1 and 2).
Nodules
Lung nodules are common in patients with endemic fungal infection, particularly histoplasmosis (Figs. 14, 15, 16, and 17) and coccidioidomycosis (Figs. 18 and 19), and they can be solitary (Fig. 14) or multiple (Fig. 18). Disseminated fungal infection, particularly in immunocompromised patients, may present as numerous tiny lung nodules in a miliary pattern (Fig. 15), an appearance indistinguishable from disseminated tuberculosis [76]. Helpful findings at initial imaging suggesting fungal infection as the cause of a pulmonary nodule rather than lung malignancy or metastatic disease include peribronchovascular nodularity or beading adjacent to the nodule (Figs. 15 and 16) and/or satellite nodules surrounding the dominant nodule [6, 73]. Ill-defined margins also favor an infectious or inflammatory etiology rather than a malignant etiology (Fig. 14). Over time, these nodules tend to decrease in size, and those due to histoplasmosis commonly calcify (Fig. 17) [6, 74]. Fungal lung nodules can also cavitate (Fig. 19), appearing initially with central lucency, and ultimately as a thick or thin-walled cavity with or without mural calcification [6, 71, 74, 76,77,78,79,80].
Lymphadenopathy
Thoracic lymph nodes (Figs. 20, 21, 22, 23, and 24) are frequently involved in the setting of histoplasmosis and coccidioidomycosis and quite uncommonly involved in the setting of blastomycosis, with unilateral hilar lymph nodes most commonly involved (Fig. 20) and sometimes also mediastinal lymph nodes (Figs. 21 and 22) [73]. Lymph nodes are commonly enlarged in the setting of active fungal infection (Fig. 23) and can undergo necrosis and coalescence (Fig. 24) [81]. The nodal disease associated with histoplasmosis commonly calcifies when subacute or healing, an evolution less commonly seen with coccidioidomycosis, rarely seen with blastomycosis, and unlike nodal disease in routine community-acquired pneumonias (Figs. 20, 21, and 22). A variety of patterns of lymph node calcification can be observed in this setting, including speckled or stippled calcifications (Fig. 20), peripheral or “egg-shell” calcification, and dense, confluent calcification (Fig. 22) [82, 83].
Fibrosing mediastinitis
Fibrosing mediastinitis is a rare, generally late, complication of endemic fungal infection, almost exclusively histoplasmosis although cases due to blastomycosis and coccidioidomycosis have been reported [84, 85]. It involves large amounts of mature, concentrically deposited, dense, paucicellular collagen infiltrate, and that obliterates mediastinal adipose tissue and that can compress or constrict mediastinal and hilar structures in response to fungal antigen in genetically susceptible individuals [86,87,88]. Fibrosing mediastinitis is best characterized with contrast-enhanced CT and tends to manifest as unilateral mediastinal and/or hilar, relatively localized, infiltrative, variably enhancing, and often calcified soft tissue, but can be extensive and bilateral (Fig. 25) [89,90,91]. Associated airway obstruction due to tracheal or bronchial narrowing may be especially evident in children due to greater airway compliance, but other potentially affected structures include the pulmonary veins and arteries, superior vena cava and brachiocephalic veins, aorta and aortic branches, esophagus, thoracic duct, pericardium, recurrent laryngeal and phrenic nerves, and autonomic ganglia [86, 92]. Close follow-up may be sufficient in some cases, but in patients with symptoms attributable to fibrosing mediastinitis nonsurgical (e.g., vascular stenting) or surgical interventions may be required [91].
Extra-thoracic imaging manifestations
Skin and soft tissues
Skin and soft-tissue involvement (Fig. 26) is the most common extra-thoracic manifestation of blastomycosis and the most common presenting finding in children [17, 93]. Imaging may show skin thickening, subcutaneous soft tissue inflammation, and fluid collections [73]. In the setting of coccidioidomycosis infection erythema nodosum can be seen, presenting as multiple painful, erythematous, indurated nodules that typically affect the extremities [40]. Imaging generally is not required to evaluate the skin and soft tissue manifestations of endemic fungal infections, but these findings may be the first identified manifestation of disease.
Musculoskeletal system
Fungal bone and joint infections are most commonly seen with coccidioidomycosis (Figs. 26 and 27) and blastomycosis (Figs. 28 and 29) and are rarely seen with histoplasmosis [94, 95]. Bone and joint infections are more commonly unifocal but can be multifocal [94]. Systemic signs and symptoms are often absent and inflammatory markers can be normal [96].
Fungal osteomyelitis can involve the axial or appendicular skeleton. On radiographs and CT fungal osteomyelitis can appear as “punched-out” lytic lesions (Fig. 27 and 30a), permeative pattern lytic lesions, or frank osseous destruction, and periosteal new bone formation is uncommon [95, 97,98,99]. MRI will show T1-weighted hypointense and T2-weighted hyperintense marrow signal similar to that seen with other forms of osteomyelitis and can show associated findings such as intraosseous abscess formation (Fig. 28), osseous destruction (Fig. 30b), and/or soft tissue findings that are often seen in the setting of fungal osteomyelitis, including inflammation, abscess, or sinus tract [96,97,98,99].
Fungal infectious arthritis is most commonly monoarticular, typically involving large joints, with the knee being the most commonly involved joint [94]. Synovial infection is often associated with adjacent bone erosion and/or destruction similar to that seen with tuberculosis infection [94, 97, 99]. On the other hand, in the case of blastomycosis, joint infection often results from the spread of infection from an adjacent site of osteomyelitis [95, 96, 98, 99]. When present, radiographic findings of septic arthritis can include effusion, periarticular osteopenia, erosion(s), and/or osseous destruction. MRI findings can include effusion, synovitis, perisynovial edema, cartilage destruction, periarticular bone marrow edema, and/or erosions. In addition to infectious arthritis, both coccidioidomycosis and histoplasmosis can have a sterile, migratory polyarthritis associated with primary pulmonary infection as part of a hypersensitivity syndrome [95, 100].
In addition to osteoarticular infection, histoplasmosis, coccidioidomycosis, and blastomycosis can all cause tenosynovitis that may or may not be adjacent to an area of osteomyelitis, with all reported cases localizing to the hand and wrist [101,102,103,104,105]. In fact, synovitis about the wrist, typically flexor tenosynovitis, seems to be the most common musculoskeletal manifestation of histoplasmosis in healthy patients [106]. On MRI fungal tenosynovitis manifests as thickened, T2-weighted hyperintense signal tenosynovium surrounding tendons with variable enhancement and surrounding soft tissue inflammation (Fig. 26) [101, 103], while on ultrasound it manifests as hypoechoic tissue surrounding tendons that can be hyperemic on color Doppler imaging [107]. When involving the flexor tendons of the wrist associated median nerve thickening can be seen [101, 107].
Central nervous system
All three endemic mycoses can involve the CNS (Figs. 31, 32, and 33). The CNS is the most common extra-thoracic site of infection for coccidioidomycosis, occurring in over one-third of children with disseminated disease [108]. The most common CNS presentation is meningitis, which appears as leptomeningeal enhancement and sometimes thickening on contrast-enhanced CT and MRI (Fig. 30) [109]. Spinal canal involvement with granulomas and spinal cord syrinx have been associated with coccidioidal meningitis [110, 111].
Intraparenchymal and/or extra-axial abscesses can occur in acute disseminated infection [73], and when intraparenchymal, abscesses can be single or multifocal (Fig. 32). Small abscesses can appear as enhancing lesions on contrast-enhanced CT or MRI, whereas larger abscesses present as rim-enhancing fluid collections that can have diffusion restriction on MRI [6, 109, 112]. Extra-axial granulomatous lesions have a propensity to occur in specific areas, such as the basilar cisterns, Sylvian fissures, and chiasmatic region. Depending on the extent of CNS involvement, obstruction of CSF flow may occur and hydrocephalus can develop [109]. Cases of blastomycosis have also been known to cause CNS disease presenting as punctate foci enhancement in the brain (Fig. 32) [113].
Abdomen
Involvement of the abdomen can occur with all three endemic mycoses and is the most common site of extra-thoracic disease in the setting of histoplasmosis infection. Involvement of the viscera, mesentery, and peritoneal cavity can be due to hematogenous and/or lymphatic dissemination, and it is most common in the immunosuppressed population (e.g., particularly pediatric patients undergoing treatment for malignancy or immunosuppressive therapy for solid organ transplant or autoimmune disorder, such as children with Crohn’s disease prescribed biologic therapy) [114,115,116,117]. Systemic dissemination and abdominal involvement also have rarely been described in infants with mostly transient immune system deficiencies and exposure to large amounts of the pathogen [118].
The spleen is the most common site of abdominal involvement in children. Splenic involvement due to histoplasmosis (Figs. 34, 35, and 36) may present as splenomegaly or as focal nodules or mass-like lesions in the setting of active infection that commonly calcify upon healing (Fig. 35); fluid collections also may be observed (Fig. 36) [119,120,121,122]. Blastomycosis and coccidioidomycosis also may rarely involve the spleen upon dissemination, presenting as splenomegaly and irregular, small nodular and/or mass-like areas of hypoenhancement on contrast-enhanced CT (Fig. 37) and hypoechogenicity on ultrasound that correspond to areas of necrosis/abscess formation at pathology [123,124,125,126].
While rare, granulomas of the liver as well as periportal lymphohistiocytic inflammation have been observed in the setting of active histoplasmosis infection [127]. Collins et al. documented that histoplasmosis is the most common cause of hepatic granulomas identified upon liver biopsy in a Midwestern U.S. pediatric cohort [128]. A mass-like liver lesion also has been described in the setting of coccidioidomycosis [129]. Liver involvement by active endemic fungal infections is rarely evident by imaging in our experience, although punctate calcifications eventually may be observed when the infection is chronic or successfully treated.
The adrenal glands and kidneys also can be rarely involved by these infections, although reports are primarily in adults. Adrenal manifestations in the setting of histoplasmosis include nonspecific adrenal gland enlargement, hypoenhancing areas on contrast-enhanced CT that reflect areas of caseous necrosis, and calcifications as well as clinical adrenal gland insufficiency [130,131,132]. Renal involvement by histoplasmosis (Figs. 38 and 39) may appear as one or more nonspecific mass-like lesions, potentially mimicking neoplasm, and parenchymal calcifications [133, 134]. There is a general paucity of reports of these infections involving the pancreas in either children or adults, although vary rare instances of mass-like pancreatic lesions due to blastomycosis have been described in adults [125, 135].
There are numerous reports of small and large bowel involvement by these infections in both children and adults. Involvement of the distal small bowel and proximal colon by histoplasmosis can mimic Crohn’s disease, with bowel wall thickening, nodularity, and ulcers seen on imaging and granulomas seen at histopathology [136]. A case report also described histoplasmosis involvement of the bowel wall as a cause of recurrent intestinal intussusception in a young child [137]. Segmental involvement of the bowel, including the colon, and associated regional lymphadenopathy due to histoplasmosis has been described in the specific setting of untreated human immunodeficiency virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). Infection of the bowel due to blastomycosis and coccidioidomycosis also can occur with dissemination, appearing as bowel wall thickening and hyperenhancement with potential associated adjacent inflammatory fat stranding and prominent vasculature [138,139,140]. Peritoneal, mesenteric, and omental involvement (i.e., granulomatous peritonitis), including discrete soft tissue lesions and ascites, is a rare manifestation of infection by these organisms, sometimes potentially mimicking malignancy or pelvic inflammatory disease [138,139,140,141,142,143].
Conclusion
Endemic fungal infections in the pediatric population are relatively uncommon and remain difficult to accurately and timely diagnose. The clinical manifestations of these infections can range widely and overlap with non-fungal infections as well as other inflammatory processes. Knowledge of the various thoracic and extra-thoracic manifestations, which can be readily identified by imaging, and a maintained high index of suspicion can facilitate timely diagnosis and management of affected children.
References
Pfaller MA, Diekema DJ (2010) Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36:1–53
Salzer HJF, Burchard G, Cornely OA et al (2018) Diagnosis and management of systemic endemic mycoses causing pulmonary disease. Respiration 96:283–301
Douglas AP, Thursky KA, Worth LJ et al (2019) FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging. Eur J Nucl Med Mol Imaging 46:166–173
Kunin JR, Blasco LF, Hamid A et al (2021) Thoracic endemic fungi in the United States: importance of patient location. Radiographics 41:380–398
Di Mango AL, Zanetti G, Penha D et al (2019) Endemic pulmonary fungal diseases in immunocompetent patients: an emphasis on thoracic imaging. Expert Rev Respir Med 13:263–277
Katragkou A, Fisher BT, Groll AH et al (2017) Diagnostic imaging and invasive fungal diseases in children. J Pediatric Infect Dis Soc 6:S22–S31
(2020) Burden of fungal Diseases in the United States. Fungal Diseases. Centers for Disease Control and Prevention. https://www.cdc.gov/fungal/cdc-and-fungal/burden.html. Accessed 01 Aug 2022
(2013) Increase in reported coccidioidomycosis - United States, 1998–2011. Morbidity and mortality weekly report, Centers for Disease Control and Prevention (CDC), pp 217–221
Vallabhaneni S, Mody RK, Walker T et al (2016) The Global Burden of Fungal Diseases. Infect Dis Clin North Am 30:1–11
(2019) Blastomycosis Statistics. Fungal Diseases. Centers for Disease Control and Prevention. https://www.cdc.gov/fungal/diseases/blastomycosis/statistics.html#three. Accessed 01 Aug 2022
(2020) Histoplasmosis Statistics. Fungal Diseases. Centers for Disease Control and Prevention. https://www.cdc.gov/fungal/diseases/histoplasmosis/statistics.html. Accessed 01 Aug 2022
(2021) About Valley Fever, UC Davis Health. https://health.ucdavis.edu/valley-fever/about-valley-fever/index.html. Accessed 01 Aug 2022
Chu JH, Feudtner C, Heydon K et al (2006) Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 42:822–825
Gusho CA, Court TA (2020) Pulmonary blastomycosis: pediatric cases emphasizing prompt identification using C-reactive protein and procalcitonin to distinguish fungal vs bacterial origin. WMJ 119:289–292
Saccente M, Woods GL (2010) Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 23:367–381
Malcolm TR, Chin-Hong PV (2013) Endemic mycoses in immunocompromised hosts. Curr Infect Dis Rep 15:536–543
Frost HM, Anderson J, Ivacic L et al (2017) Blastomycosis in children: an analysis of clinical, epidemiologic, and genetic features. J Pediatric Infect Dis Soc 6:49–56
McBride JA, Gauthier GM, Klein BS (2019) Turning on virulence: mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces. Virulence 10:801–809
Sil A, Andrianopoulos A (2014) Thermally dimorphic human fungal pathogens–polyphyletic pathogens with a convergent pathogenicity trait. Cold Spring Harb Perspect Med 5:a019794
Beaussart A, Brandhorst T, Dufrene YF et al (2015) Blastomyces virulence adhesin-1 protein binding to glycosaminoglycans is enhanced by protein disulfide isomerase. mBio 6:e01403-01415
Finkel-Jimenez B, Wuthrich M, Brandhorst T et al (2001) The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol 166:2665–2673
Klein BS (2000) Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion. Curr Opin Microbiol 3:339–343
Kuzo RS, Goodman LR (1996) Blastomycosis. Semin Roentgenol 31:45–51
Meyer KC, McManus EJ, Maki DG (1993) Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 329:1231–1236
Moore RM, Green NE (1982) Blastomycosis of bone. A report of six cases. J Bone Joint Surg Am 64:1097–1101
Fanella S, Skinner S, Trepman E et al (2011) Blastomycosis in children and adolescents: a 30-year experience from Manitoba. Med Mycol 49:627–632
Patel AJ, Gattuso P, Reddy VB (2010) Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am J Surg Pathol 34:256–261
Mukhopadhyay S (2011) Role of histology in the diagnosis of infectious causes of granulomatous lung disease. Curr Opin Pulm Med 17:189–196
Taxy JB (2007) Blastomycosis: contributions of morphology to diagnosis: a surgical pathology, cytopathology, and autopsy pathology study. Am J Surg Pathol. 31(4):615–623
Carlos WG, Rose AS, Wheat LJ et al (2010) Blastomycosis in indiana: digging up more cases. Chest 138:1377–1382
Durkin M, Witt J, Lemonte A et al (2004) Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 42:4873–4875
Dismukes WE, Bradsher RW Jr, Cloud GC et al (1992) Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 93:489–497
Panicker J, Walsh T, Kamani N (2006) Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 25:377–379
Chapman SW, Lin AC, Hendricks KA et al (1997) Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 12:219–228
Montenegro BL, Arnold JC (2010) North American dimorphic fungal infections in children. Pediatr Rev 31:e40-48
Powell DA, Schuit KE (1979) Acute pulmonary blastomycosis in children: clinical course and follow-up. Pediatrics 63:736–740
Yeoh DK, Butters C, Curtis N (2019) Endemic mycoses in children. Pediatr Infect Dis J 38:S52–S59
Kirkland TN, Fierer J (2018) Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity. Virulence 9:1426–1435
Sondermeyer Cooksey GL, Jain S, Vugia DJ (2019) Epidemiology of coccidioidomycosis among children in California, 2000–2016. Med Mycol 57:S64–S66
Maza-Morales M, Rivas-Calderón MK, Barrón-Calvillo EE et al (2020) Coccidioidomycosis in children and adolescents: an update. Curr Fungal Infect Rep 14:106–114
Ampel NM, Hoover SE (2015) Pathogenesis of coccidioidomycosis. Curr Fungal Infect Rep 9:253–258
Gabe LM, Malo J, Knox KS (2017) Diagnosis and management of coccidioidomycosis. Clin Chest Med 38:417–433
Naeem F, McCarty J, Mhaissen MN et al (2019) Extrapulmonary coccidioidomycosis among children in central california: a retrospective review. Pediatr Infect Dis J 38:1189–1194
Dimitrova D, Ross L (2016) Coccidioidomycosis: experience from a children’s hospital in an area of endemicity. J Pediatric Infect Dis Soc 5:89–92
(2020) Coccidioidomycosis. Fungal Diseases. Centers for Disease Control and Prevention. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/index.html. Accessed 01 Aug 2022
Adam RD, Elliott SP, Taljanovic MS (2009) The spectrum and presentation of disseminated coccidioidomycosis. Am J Med 122:770–777
Stockamp NW, Thompson GR 3rd (2016) Coccidioidomycosis. Infect Dis Clin North Am 30:229–246
Guarner J, Brandt ME (2011) Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24:247–280
Sangoi AR, Rogers WM, Longacre TA et al (2009) Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am J Clin Pathol 131:364–375
Dizon D, Mitchell M, Dizon B et al (2019) The utility of real-time polymerase chain reaction in detecting Coccidioides immitis among clinical specimens in the Central California San Joaquin Valley. Med Mycol 57:688–693
Galgiani JN, Ampel NM, Blair JE et al (2016) 2016 Infectious Diseases Society of America (IDSA) Clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis 63:e112-146
Connelly MB, Zerella JT (2000) Surgical management of coccidioidomycosis in children. J Pediatr Surg 35:1633–1634
Benedict K, Mody RK (2016) Epidemiology of histoplasmosis outbreaks, United States, 1938–2013. Emerg Infect Dis 22:370–378
Diaz JH (2018) Environmental and wilderness-related risk factors for histoplasmosis: more than bats in caves. Wilderness Environ Med 29:531–540
Armstrong PA, Jackson BR, Haselow D et al (2018) Multistate epidemiology of histoplasmosis, United States, 2011–2014. Emerg Infect Dis 24:425–431
Goodwin RA Jr, Des Prez RM (1973) Pathogenesis and clinical spectrum of histoplasmosis. South Med J 66:13–25
Kauffman CA (2007) Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20:115–132
Rodriguez L, Voorhies M, Gilmore S et al (2019) Opposing signaling pathways regulate morphology in response to temperature in the fungal pathogen Histoplasma capsulatum. PLoS Biol 17:e3000168
Cleare LG, Zamith-Miranda D, Nosanchuk JD (2017) Heat shock proteins in histoplasma and paracoccidioides. Clin Vaccine Immunol 24
Garfoot AL, Rappleye CA (2016) Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis. FEBS J 283:619–633
Youseff BH, Holbrook ED, Smolnycki KA et al (2012) Extracellular superoxide dismutase protects histoplasma yeast cells from host-derived oxidative stress. PLoS Pathog 8:e1002713
Horwath MC, Fecher RA, Deepe GS Jr (2015) Histoplasma capsulatum, lung infection and immunity. Future Microbiol 10:967–975
Mittal J, Ponce MG, Gendlina I et al (2019) Histoplasma capsulatum: mechanisms for pathogenesis. Curr Top Microbiol Immunol 422:157–191
Azar MM, Loyd JL, Relich RF et al (2020) Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes. Semin Respir Crit Care Med 41:13–30
Fischer GB, Mocelin H, Severo CB et al (2009) Histoplasmosis in children. Paediatr Respir Rev 10:172–177
Goodwin RA Jr, Shapiro JL, Thurman GH et al (1980) Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 59:1–33
Lum J, M ZA, McCollister B, Henao-Martinez AF (2018) Miliary histoplasmosis in a patient with rheumatoid arthritis. Case Rep Med 2018:2723489
Prevention CfDCa (2020) Histoplasmosis. Fungal Diseases
Mukhopadhyay S, Katzenstein AL (2010) Biopsy findings in acute pulmonary histoplasmosis: unusual histologic features in 4 cases mimicking lymphomatoid granulomatosis. Am J Surg Pathol 34:541–546
Wheat LJ, Freifeld AG, Kleiman MB et al (2007) Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45:807–825
Rozovsky K, Bunge M, Higgins R et al (2019) Imaging patterns of pediatric pulmonary blastomycosis. AJR Am J Roentgenol 212:905–913
Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner society: glossary of terms for thoracic imaging. Radiology 246:697–722
Fang W, Washington L, Kumar N (2007) Imaging manifestations of blastomycosis: a pulmonary infection with potential dissemination. Radiographics 27:641–655
McAdams HP, Rosado-de-Christenson ML, Lesar M et al (1995) Thoracic mycoses from endemic fungi: radiologic-pathologic correlation. Radiographics 15:255–270
Ananthakrishnan L, Sharma N, Kanne JP (2009) Wegener’s granulomatosis in the chest: high-resolution CT findings. AJR Am J Roentgenol 192:676–682
Key T (2019) Acute Histoplasmosis. Endemic Mycoses
Alkrinawi S, Reed MH, Pasterkamp H (1995) Pulmonary blastomycosis in children: findings on chest radiographs. AJR Am J Roentgenol 165:651–654
Chick EW, Dillon ML, Tahanasab A (1977) Acute cavitary histoplasmosis. Chest 71:674–676
Hage CA, Knox KS, Wheat LJ (2012) Endemic mycoses: overlooked causes of community acquired pneumonia. Respir Med 106:769–776
Manglani R, Pavosevic HT, Han L et al (2020) Close encounters of three kinds: case-based report of endemic mycoses in the environs of New York city. Respir Med Case Rep 30:101106
Kirchner SG, Hernanz-Schulman M, Stein SM et al (1991) Imaging of pediatric mediastinal histoplasmosis. Radiographics 11:365–381
Gross BH, Schneider HJ, Proto AV (1980) Eggshell calcification of lymph nodes: an update. AJR Am J Roentgenol 135:1265–1268
Skalina T, Gaillard F Eggshell calcification (lymph nodes). Radiopaedia
Lagerstrom CF, Mitchell HG, Graham BS et al (1992) Chronic fibrosing mediastinitis and superior vena caval obstruction from blastomycosis. Ann Thorac Surg 54:764–765
Argueta F, Villafuerte D, Castaneda-Nerio J et al (2020) Successful management of fibrosing mediastinitis with severe vascular compromise: report of two cases and literature review. Respir Med Case Rep 29:100987
McNeeley MF, Chung JH, Bhalla S et al (2012) Imaging of granulomatous fibrosing mediastinitis. AJR Am J Roentgenol 199:319–327
Strock SB, Gaudieri S, Mallal S et al (2015) Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 - a case control study. BMC Infect Dis 15:206
Rossi SE, McAdams HP, Rosado-de-Christenson ML et al (2001) Fibrosing mediastinitis. Radiographics 21:737–757
Sherrick AD, Brown LR, Harms GF et al (1994) The radiographic findings of fibrosing mediastinitis. Chest 106:484–489
Weinstein JB, Aronberg DJ, Sagel SS (1983) CT of fibrosing mediastinitis: findings and their utility. AJR Am J Roentgenol 141:247–251
Garrana SH, Buckley JR, Rosado-de-Christenson ML et al (2019) Multimodality imaging of focal and diffuse fibrosing mediastinitis. Radiographics 39:651–667
Siberry GK, Abzug MJ, Nachman S, et al (2013) Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J 32 Suppl 2:i-KK4
Gill JA, Gerald B (1968) Blastomycosis in childhood. Radiology 91:958 passim
Rammaert B, Gamaletsou MN, Zeller V et al (2014) Dimorphic fungal osteoarticular infections. Eur J Clin Microbiol Infect Dis 33:2131–2140
Kohli R, Hadley S (2005) Fungal arthritis and osteomyelitis. Infect Dis Clin North Am 19:831–851
Bariteau JT, Waryasz GR, McDonnell M et al (2014) Fungal osteomyelitis and septic arthritis. J Am Acad Orthop Surg 22:390–401
Zeppa MA, Laorr A, Greenspan A et al (1996) Skeletal coccidioidomycosis: imaging findings in 19 patients. Skeletal Radiol 25:337–343
Weber CL, Bartley D, Al-Thaqafi A et al (2007) Blastomyces dermatitidis osteomyelitis of the tibia. Am J Orthop (Belle Mead NJ) 36:29–32
Jain R, Singh K, Lamzabi I et al (2014) Blastomycosis of bone: a clinicopathologic study. Am J Clin Pathol 142:609–616
Darouiche RO, Cadle RM, Zenon GJ et al (1992) Articular histoplasmosis. J Rheumatol 19:1991–1993
Vitale MA, Roden AC, Rizzo M (2015) Tenosynovitis of the wrist and thumb and carpal tunnel syndrome caused by Histoplasma capsulatum: case report and review of the literature. Hand (N Y) 10:54–59
Campbell M, Kusne S, Renfree KJ et al (2015) Coccidioidal tenosynovitis of the hand and wrist: report of 9 cases and review of the literature. Clin Infect Dis 61:1514–1520
Popa MA, Jebson PJ, Condit DP (2012) Blastomycotic extensor tenosynovitis of the hand: a case report. Hand (N Y) 7:323–326
Erpelding JM, Meister DW, Daley RA (2012) Pediatric blastomycotic osteomyelitis of the hand. Hand (N Y) 7:442–446
Hankins CL (2009) Blastomycotic hand infections. Scand J Plast Reconstr Surg Hand Surg 43:166–170
McCabe MP, Heck RK (2010) Histoplasma osteomyelitis simulating giant-cell tumor of the distal part of the radius: a case report. J Bone Joint Surg Am 92:708–714
Woods RJ, Reyes EJ, Knight JS (2018) Histoplasma tenosynovitis revealed by fungal culture in a patient treated with infliximab. J Rheumatol 45:284–285
McCarthy MW, Kalasauskas D, Petraitis V et al (2017) Fungal infections of the central nervous system in children. J Pediatric Infect Dis Soc 6:e123–e133
Jain KK, Mittal SK, Kumar S et al (2007) Imaging features of central nervous system fungal infections. Neurol India 55:241–250
Jackson NR, Blair JE, Ampel NM (2019) Central nervous system infections due to coccidioidomycosis. J Fungi (Basel) 5
Lammering JC, Iv M, Gupta N et al (2013) Imaging spectrum of CNS coccidioidomycosis: prevalence and significance of concurrent brain and spinal disease. AJR Am J Roentgenol 200:1334–1346
Zalduondo FM, Provenzale JM, Hulette C et al (1996) Meningitis, vasculitis, and cerebritis caused by CNS histoplasmosis: radiologic-pathologic correlation. AJR Am J Roentgenol 166:194–196
Kochar PS, Lath CO, Klein AP et al (2016) Multimodality imaging in cranial blastomycosis, a great mimicker: case-based illustration with review of clinical and imaging findings. Indian J Radiol Imaging 26:120–125
Kothadia JP, Kone V, Giashuddin S (2017) Granulomatous hepatitis: a rare primary manifestation of disseminated histoplasmosis in a renal transplant recipient. J Gastrointestin Liver Dis 26:114
Ferguson-Paul K, Park C, Childress S et al (2018) Disseminated histoplasmosis in pediatric kidney transplant recipients-a report of six cases and review of the literature. Pediatr Transplant 22:e13274
Hess J, Fondell A, Fustino N et al (2017) Presentation and treatment of histoplasmosis in pediatric oncology patients: case series and review of the literature. J Pediatr Hematol Oncol 39:137–140
Adderson EE (2004) Histoplasmosis in a pediatric oncology center. J Pediatr 144:100–106
Odio CM, Navarrete M, Carrillo JM, Mora L, Carranza A (1999) Disseminated histoplasmosis in infants. Pediatr Infect Dis J 18:1065–1068
Fayyaz J (2020) Histoplasmosis: background, pathophysiology, etiology. medscape
Kurowski R, Ostapchuk M (2002) Overview of histoplasmosis. Am Fam Physician 66:2247–2252
Radin DR (1991) Disseminated histoplasmosis: abdominal CT findings in 16 patients. AJR Am J Roentgenol 157:955–958
Ubesie AC, Okafo OC, Ibeziako NS et al (2013) Disseminated histoplasmosis in a 13-year-old girl: a case report. Afr Health Sci 13:518–521
Keckich DW, Blair JE, Vikram HR (2010) Coccidioides fungemia in six patients, with a review of the literature. Mycopathologia 170:107–115
Dubuisson RL, Jones TB (1983) Splenic abscess due to blastomycosis: scintigraphic, sonographic, and CT evaluation. AJR Am J Roentgenol 140:66–68
Deutsch JC, Burke TL, Nelson TC (2007) Pancreatic and splenic blastomycosis in an immune-competent woman diagnosed by endoscopic ultrasonography-guided fine-needle aspiration. Endoscopy 39(Suppl 1):E272-273
Redemann JP, Thornton KA, Raval JS et al (2021) Disseminated coccidioidomycosis in an immunocompetent patient: report of a case and review of the literature. Human Pathology: Case Reports 24:200521
Lamps LW, Molina CP, West AB et al (2000) The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol 113:64–72
Collins MH, Jiang B, Croffie JM et al (1996) Hepatic granulomas in children. A clinicopathologic analysis of 23 cases including polymerase chain reaction for histoplasma. Am J Surg Pathol 20:332–338
Goldberg B, Loeffler AM (1999) Respiratory distress and a liver mass. Pediatr Infect Dis J 18(1105–1106):1113–1104
Kenney PJ, Stanley RJ (1987) Calcified adrenal masses. Urol Radiol 9:9–15
Wheat LJ, Slama TG, Eitzen HE et al (1981) A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med 94:331–337
Wilson DA, Muchmore HG, Tisdal RG et al (1984) Histoplasmosis of the adrenal glands studied by CT. Radiology 150:779–783
den Bakker MA, Goemaere NN, Severin JA et al (2009) Histoplasma-associated inflammatory pseudotumour of the kidney mimicking renal carcinoma. Virchows Arch 454:229–232
Kedar SS, Eldar S, Abrahamson J et al (1988) Histoplasmosis of kidneys presenting as chronic recurrent renal disease. Urology 31:490–494
Riyat N, Wells T, Jackson C, et al (2018) Disseminated blastomycosis with gastrointestinal involvement of the pancreas: 1387. Official journal of the American College of Gastroenterology | ACG 113:S796
Steiner SJ, Kleiman MB, Corkins MR et al (2009) Ileocecal histoplasmosis simulating Crohn disease in a patient with hyperimmunoglobulin E syndrome. Pediatr Infect Dis J 28:744–746
Carmona MG, Allen MS (1958) Recurrent intussusception in a six year old child with histoplasmosis of Peyer’s patches. J Fla Med Assoc 44:955–956
Zhou S, Ma Y, Chandrasoma P (2015) Small bowel dissemination of coccidioidomycosis. Case Rep Pathol 2015:403671
Weisman IM, Moreno AJ, Parker AL et al (1986) Gastrointestinal dissemination of coccidioidomycosis. Am J Gastroenterol 81:589–593
Orlowski HLP, McWilliams S, Mellnick VM et al (2017) Imaging spectrum of invasive fungal and fungal-like infections. Radiographics 37:1119–1134
Rimtepathip PP, Erickson A, Katner H, Bakri Y (2016) Disseminated histoplasmosis presenting as pelvic inflammatory disease. Clin Case Rep 4:76–80
Levy AD, Shaw JC, Sobin LH (2009) Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics 29:347–373
Saw EC, Shields SJ, Comer TP et al (1974) Granulomatous peritonitis due to Coccidioides immitis. Arch Surg 108:369–371
Author information
Authors and Affiliations
Contributions
All authors contributed to the drafting and editing of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key take-home points
• The incidences of endemic fungal infections in children remain unknown, as the majority of these infections are asymptomatic or cause only minor illness.
• Severe and/or disseminated endemic fungal infection is most often associated with immunocompromised state but can occur in immunocompetent children.
• Symptomatic endemic fungal infections frequently present with clinical signs and symptoms of pulmonary infection, with radiologic findings potentially mimicking non-fungal community-acquired pneumonia or tuberculosis.
• Endemic fungal infections can spread via the lymphatic system or blood stream, leading to extra-pulmonary sites of disease.
• Imaging, and perhaps most importantly a radiologist with a maintained high index of suspicion for endemic fungal infection, is critical to the prompt diagnosis and treatment of moderate-severe endemic fungal infections, as the diagnosis is commonly delayed due to nonspecific clinical presentation, overlap with non-fungal infections, and slow organism growth upon tissue and/or fluid culture.
• Aside from potentially assisting with diagnosis, cross-sectional imaging (e.g., CT, MRI, or ultrasound) of extra-pulmonary infection can be useful for determining the extent and severity of the disease.
• In general, there is a paucity of studies describing the radiologic features of endemic fungal infections and their associations with clinical outcomes in children, and therefore much of our knowledge is extrapolated from adult medical literature and our clinical experience. Despite this fact, there is likely considerable overlap in pediatric and adult clinical and imaging manifestations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Campbell, A.P., Qiu, L., Dillman, J.R. et al. Endemic mycoses in children in North America: a review of radiologic findings. Pediatr Radiol 53, 984–1004 (2023). https://doi.org/10.1007/s00247-023-05636-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-023-05636-3